Sana Biotechnology Statistics
Total Valuation
SANA has a market cap or net worth of $829.96 million. The enterprise value is $777.84 million.
Important Dates
The last earnings date was Tuesday, March 3, 2026, after market close.
| Earnings Date | Mar 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SANA has 266.87 million shares outstanding. The number of shares has increased by 9.68% in one year.
| Current Share Class | 266.87M |
| Shares Outstanding | 266.87M |
| Shares Change (YoY) | +9.68% |
| Shares Change (QoQ) | +5.91% |
| Owned by Insiders (%) | 6.95% |
| Owned by Institutions (%) | 51.06% |
| Float | 177.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.89 |
| Quick Ratio | 1.76 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -118.70% and return on invested capital (ROIC) is -40.33%.
| Return on Equity (ROE) | -118.70% |
| Return on Assets (ROA) | -26.00% |
| Return on Invested Capital (ROIC) | -40.33% |
| Return on Capital Employed (ROCE) | -56.47% |
| Weighted Average Cost of Capital (WACC) | 13.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.72M |
| Employee Count | 142 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.91% in the last 52 weeks. The beta is 1.96, so SANA's price volatility has been higher than the market average.
| Beta (5Y) | 1.96 |
| 52-Week Price Change | +32.91% |
| 50-Day Moving Average | 4.05 |
| 200-Day Moving Average | 3.93 |
| Relative Strength Index (RSI) | 35.20 |
| Average Volume (20 Days) | 2,815,608 |
Short Selling Information
The latest short interest is 35.83 million, so 13.42% of the outstanding shares have been sold short.
| Short Interest | 35.83M |
| Short Previous Month | 37.27M |
| Short % of Shares Out | 13.42% |
| Short % of Float | 20.19% |
| Short Ratio (days to cover) | 17.91 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -190.96M |
| Pretax Income | -244.17M |
| Net Income | -244.17M |
| EBITDA | -178.21M |
| EBIT | -190.96M |
| Earnings Per Share (EPS) | -$0.96 |
Full Income Statement Balance Sheet
The company has $138.38 million in cash and $86.26 million in debt, with a net cash position of $52.12 million or $0.20 per share.
| Cash & Cash Equivalents | 138.38M |
| Total Debt | 86.26M |
| Net Cash | 52.12M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 160.88M |
| Book Value Per Share | 0.60 |
| Working Capital | 69.95M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$143.83 million and capital expenditures -$938,000, giving a free cash flow of -$144.77 million.
| Operating Cash Flow | -143.83M |
| Capital Expenditures | -938,000 |
| Depreciation & Amortization | 12.75M |
| Net Borrowing | -347,000 |
| Free Cash Flow | -144.77M |
| FCF Per Share | -$0.54 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SANA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.68% |
| Shareholder Yield | -9.68% |
| Earnings Yield | -29.42% |
| FCF Yield | -17.44% |
Analyst Forecast
The average price target for SANA is $7.50, which is 141.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.50 |
| Price Target Difference | 141.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -8.84% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |